Increasing awareness about the health concerns due to obesity and overweight resulting in the increasing demand for the anti-obesity drugs and bariatric procedures which fuel the growth of the global obesity management market.
The global oxytocic pharmaceuticals market expected to increase at a CAGR of 9.7% in terms of revenues during the forecast period -2026. China and APEJC will continue to be the leading markets during the forecast period.
The global microfluidics market is expected to increase at a y-o-y growth rate of over 14.4% and reach US$ 11,295.5 Mn in revenues in 2026. North America and APEJ collectively accounted for nearly 40.3% revenue share of the market in 2016.
The worldwide medical X-ray detectors market is anticipated for a steady growth with a robust 6.1% CAGR throughout the assessment period 2017-2022.
The worldwide market will be accounting for a valuation of more than US$ 2,500 Million through the end of the predicted year 2025, up from a market valuation of around US$ 1,400 Million during the year 2017. The revenue growth of the worldwide market is also projected to increase at a healthy 7.3% CAGR for the predicted duration of 2017-2025. The expansion is the outcome of new technological progressions and the manufacturers are gearing up to make full utilization of it through the introduction of fresh products in the market.
The vendor landscape of the global market for pacemaker devices is moderately fragmented, thanks to the presence of several established medical companies, observes RRI in a recent report. In the next few years, the market is likely to become more crowded and competitive owing to the rising number of specialist players in the market globally. To remain competitive in such intense dynamics, companies have begun focusing more on innovations and expansion of business across promising emerging markets.
The worldwide market for clostridium difficile infection treatment is considered to account for a market valuation in excess of US$ 1,316.7 Million through 2025 end, up from an approximated figure of US$ 752.3 Million in 2016 end and creating an incremental opportunity of about US$ 519.6 Mn during 2017 to 2025. The global market for clostridium difficile infection treatment is likely to see firm expansion all through the calculated period with a 6.5% CAGR in value terms.
According to the report by Research Report Insights (RRI), in terms of product type, consumables is expected to witness highest growth rate owing to efficiency and therapeutic grade of these essential oils on applying topically or inhaling directly
With increasing number of people suffering from diabetes, managing and controlling diabetes has become critical. Hence being user-friendly and portable, artificial pancreas systems are gaining popularity across the globe.
Increasing risk of obesity and aging population has given rise to the cases of knee osteoarthritis. Hence viscosupplementation or injection of hyaluronic acid is a medical process in which, fluid is injected in joint.
Copyrights © 2018 Research Report Insights. All rights reserved.